Estimates Revisions Sionna Therapeutics, Inc.
Stocks
SION
US8294011080
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 4.910 USD | -3.73% |
|
-6.12% | -88.07% |
| 09-20 | Sionna Therapeutics, Inc.(NasdaqGM:SION) dropped from S&P Biotechnology Select Industry Index | CI |
| 09-15 | Wedbush Raises Price Target on Sionna Therapeutics to $6 From $5, Keeps Neutral Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- SION Stock
- Consensus Sionna Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
